1) Domchek SM, Friebel TM, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010; 304 (9): 967-975. (PubMed Abstract)
2) King MC, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (nsabp-p1) Breast Cancer Prevention Trial. JAMA 2001; 286 (18):2251-2256 (PubMed Abstract)
3)McLaughlin JR, Risch HA, Lubinski J, et al. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study. Lancet Oncology 2007; 8 (1): 26-34. (PubMed Abstract)
4) BRCA2 Gene Now Connected to Lung Cancer, Doubling a Smoker's Risk. June 02, 2014, Lebanon, NH. Genetic Causes of lung cancer explored in global genome project. http://cancer.dartmouth.edu/about_us/newsdetail/70931/ (Accessed Oct 2015)
National Cancer Institute: http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet - National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/risk/BRCA.
Permission to use the BRCA statistics table for this webpage, and associated book, was given by The Royal Marsden Hospital in June 2015.
The information contained on my website is for general information purposes only. In no event shall I be liable for any actions that are taken as a result of the information provided on this webpage. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis or treatment.